Maine Immunization Program Weekly Update - January 17, 2025

Maine Immunization Program

Weekly Update

January 17, 2025

logo


Data Logger Updates

DATA LOGGER

We are in the final stages of purchasing the new VFC 800-WiFi Data Logger with Smart Probe and anticipate shipments to take place starting early February. A communication will be sent out next week with additional details.

If you have not yet completed the required actions below, please do so as ASAP.   .

Instructions for the next steps were sent out in previous communications. 

IMPORTANT – Actions Required: Do Not Discard Current Data Loggers: 

  • Continue using your current data loggers as back-ups.    
  • Ensure back-up data loggers have a valid calibration certificate. 

Pre-Training Preparation

Before your scheduled training session, the provider site’s IT department must complete the following:

Download Software 

  • Visit Control Solutions Software Downloads.    
  • Select “VFC800-WiFi” from the drop down menu.    
  • Ensure your IT administrator has admin rights to install the software on your PC.   
  • You will need to know the Wi-Fi access point credentials (network name and password).   

Review QuickStart Guide 


Prepare for ice, fire, and other disasters

Practice your vaccine storage emergency plan now

Power outages create emergency conditions that can damage your valuable vaccine inventory. For this reason, every site that stocks vaccines, including all Vaccines for Children (VFC) sites need an emergency plan. Emergency plans only work when staff are trained.

This month is a good time to refresh everyone’s training. Build redundancy, flexibility, and communication into your plan. Consider: 

  • Equipment backup options 
  • Alternate storage options 
  • Vaccine transport plans 
  • Circumstances where the physical risk to staff must be prioritized over vaccines 

Your plan should specify at least one facility where current staff are willing to receive and properly store your vaccine inventory if it must be relocated. The CDC’s Storage and Handling Toolkit provides detailed instructions on monitoring temperatures during a power outage and what to do once proper storage conditions are restored. Prevent avoidable vaccine waste by training your staff on emergency procedures, including after-hours roles and responsibilitiesHave a printed copy of your plan available on or near your storage unit before your printer loses power! 

Beginning the Conversation at Age 9: Evidence for Earlier Initiation of HPV Vaccination

Vermont's HPV task force is holding a webinar next Friday, January 24 from 12-1 PM to discuss starting HPV vaccination at 9 years of age.

Please share this opportunity widely!

For more information, please visit the Vermonters Taking Action Against Cancer (VTAAC) website.

Register here!

hpv

Learn the Real Facts About Childhood Vaccines

getreal

In late December, the U.S. Department of Health and Human Services (HHS) launched the Let’s Get Real campaign to cut through the noise of misinformation and give parents the balanced information they need about childhood vaccines. The campaign provides verifiable facts and shares stories from doctors and peers on why most of us rely on vaccines to protect our children. 

 Let’s Get Real campaign provides unbiased answers that will help separate fact from fiction. Learn why most adults support childhood vaccines and get the information needed to choose confidently.


January is Cervical Health Awareness Month; HPV vaccination prevents cancer 

January

January is Cervical Health Awareness Month, a great time to share the importance of HPV vaccination. Almost all cervical cancer is linked to infection with high-risk HPV strains, a very common virus transmitted through intimate contact.  

CDC recommends HPV vaccination for everyone 26 years old or younger, beginning as early as age 9. Adults age 27 through 45 years who are not already vaccinated may decide to get the HPV vaccine after speaking with their clinician.  Protect your patients from cervical cancer, and the many other HPV-related cancers affecting men and women, by recommending, promoting, and offering the HPV vaccine.  


Nirsevimab Remains Available

As MIP continues to receive additional allocations from the Center for Disease Control and Prevention (CDC), ordering for nirsevimab remains open each week allowing provider sites to order the number of doses needed to accommodate their patient population throughout the Respiratory Syncytial Virus (RSV) season.  

  • Nirsevimab 50 mg is now available to order at a maximum quantity of 100 doses per site.  
  • Nirsevimab 100 mg remains open at 75 doses per site.  

**All orders for nirsevimab MUST be placed separate from regular vaccine orders.